title: Different role of liver dysfunction and damage in increasing serum CA 19-9, TPA, and CEA in patients with pancreatic cancer.
authors.forename: C
authors.initials: C
authors.lastname: Fabris
authors.forename: D
authors.initials: D
authors.lastname: Basso
authors.forename: T
authors.initials: T
authors.lastname: Meggiato
authors.forename: G
authors.initials: G
authors.lastname: Del Favero
authors.forename: A
authors.initials: A
authors.lastname: Piccoli
authors.forename: P
authors.initials: P
authors.lastname: Fogar
authors.forename: M P
authors.initials: MP
authors.lastname: Panozzo
authors.forename: D
authors.initials: D
authors.lastname: Faggian
authors.forename: R
authors.initials: R
authors.lastname: Naccarato
mesh_terms: D015295:Antigens, Tumor-Associated, Carbohydrate / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002272:Carcinoembryonic Antigen / Q000378:metabolism*; D006801:Humans; D008107:Liver Diseases / Q000150:complications* / Q000276:immunology; D010190:Pancreatic Neoplasms / Q000276:immunology*; D010455:Peptides / Q000378:metabolism*; D019396:Tissue Polypeptide Antigen
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D010455:Peptides; D019396:Tissue Polypeptide Antigen